Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SNMX

Senomyx (SNMX) Stock Price, News & Analysis

Senomyx logo

About Senomyx Stock (NASDAQ:SNMX)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$1.49
$1.49
50-Day Range
N/A
52-Week Range
$0.83
$1.71
Volume
N/A
Average Volume
151,720 shs
Market Capitalization
$72.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Remove Ads
Receive SNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter.

SNMX Stock News Headlines

Disty Technologies DYT
AKD Securities Ltd Ordinary Shares AKDSL
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.
NZ Automotive Investments Ltd (NZA)
Senomyx, Inc.(SNMX)
See More Headlines

SNMX Stock Analysis - Frequently Asked Questions

Senomyx, Inc. (NASDAQ:SNMX) posted its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC) and DURECT (DRRX).

Company Calendar

Last Earnings
8/02/2018
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SNMX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$29.32 million
Price / Cash Flow
N/A
Book Value
$0.39 per share
Price / Book
3.82

Miscellaneous

Free Float
N/A
Market Cap
$72.03 million
Optionable
Optionable
Beta
1.33
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:SNMX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners